Nike partners with Chipotle, the favorite restaurant of Doernbecher Freestyle patient-designer Oli Fasone-Lancaster to design a unique custom-made Air Force 1 shoe created exclusively for him.

Rebecca Spain, M.D., discusses how the Department of Veterans Affairs Multiple Sclerosis Centers of Excellence operate as a nationwide hub-and-spoke network designed to ensure every veteran with multiple sclerosis has access to specialized, multidisciplinary care wherever they live.

Lara Heiser, Ph.D., who chairs the American Association for Cancer Research’s Cancer Evolution Working Group, successfully advocated for the AACR to host a special conference in December to explore the evolution principles of cancer from its initiation to relapse; Heiser says: “The CEWG has been quite active in building a community of researchers to promote the integration of evolutionary principles of cancer into all areas of cancer research, and bringing those ideas to the broader AACR community."

At his monthly media availability, Shereef Elnahal, M.D., voices concern about potential cuts to the 340-B program, which requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for many uninsured and low-income patients.

Legacy Health President and CEO Goerge Brown, M.D., shares his thoughts on the termination of the OHSU + Legacy Health integration and the future of Legacy Health.

The Kids Making Miracles Club at Wilsonville High School hosts an annual holiday bazaar in support of Doernbecher Children’s Hospital and featuring 90 local vendors with products tailored to the holiday season.

In the late 1980s Brian Druker, M.D., theorized that kinase inhibitors could be transformative for cancer care; specifically, that a small molecule could block the activated kinase that characterizes chronic myeloid leukemia. In 1996 he and a colleague reported that the small molecule, their agent, wiped out cancer-causing CML cells in preclinical models. This finding sparked decades of kinase inhibitor research. Recently, the FDA recently approved the 100th small-molecule kinase inhibitor, and drug makers and scientists continue to mine kinases for potential drug targets.

Dawn Nolt, M.D., joined Elnahal at the event to urge people to take preventive measures to protect themselves and others from respiratory illness.

Dawn Nolt, M.D., joined Elnahal at the event to urge people to take preventive measures to protect themselves and others from respiratory illness.

At his monthly media availability, Shereef Elnahal, M.D., voices concerns about potential cuts to the 340-B program, which requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for many uninsured and low-income patients.